Structures of native GLP-1, exenatide, and liraglutide. The N-terminal... | Download Scientific Diagram
Exenatide - Wikipedia
A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1 - Czech - 2018 - Hepatology
Differential Protective Effects of Exenatide, an Agonist of GLP-1 Receptor and Piragliatin, a Glucokinase Activator in Beta Cell Response to Streptozotocin-Induced and Endoplasmic Reticulum Stresses
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors | Circulation
Spinal microglial β‐endorphin signaling mediates IL‐10 and exenatide‐induced inhibition of synaptic plasticity in neuropathic pain - Ma - 2021 - CNS Neuroscience & Therapeutics - Wiley Online Library
Formation Mechanism, In vitro and In vivo Evaluation of Dimpled Exenatide Loaded PLGA Microparticles Prepared by Ultra-Fine Particle Processing System | SpringerLink
A schematic representation of the mechanisms of increased macrophage... | Download Scientific Diagram
Exenatide - Stepwards
Targeting GLP-1 receptor trafficking to improve agonist efficacy | Nature Communications
Frontiers | GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects | Endocrinology
Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes - ScienceDirect
Mechanisms by which GLP-1 agonists may exert beneficial effects on the... | Download Scientific Diagram
Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus
Recent updates on GLP-1 agonists: Current advancements & challenges - ScienceDirect
GLP-1 analogs
Recent updates on GLP-1 agonists: Current advancements & challenges - ScienceDirect
Exenatide Once Weekly: A Review of Pharmacology and Treatment Considerations in Type 2 Diabetes - Clinical Therapeutics
![PDF] Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/86bbc20c1f90516619b981d247b1d6cdb8e7b90b/3-Figure1-1.png "PDF] Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial | Semantic Scholar")
PDF] Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial | Semantic Scholar
Incretin - Wikipedia
Frontiers | GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects | Endocrinology
Exenatide – Beyond the Dish
Pharmacokinetic/pharmacodynamic studies on exenatide in diabetic rats | Acta Pharmacologica Sinica
Frontiers | GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms | Pharmacology
